| Transaction Date | Recipient | Shares | Type | Price | Value |
|---|---|---|---|---|---|
| 30th June 2020 | Arthur J Klausner | 323 | Exercise of derivative | $0.00 | |
| 30th June 2020 | Christopher M Starr | 323 | Exercise of derivative | $0.00 | |
| 30th June 2020 | Raymond Anderson | 323 | Exercise of derivative | $0.00 | |
| 30th June 2020 | Michael J Brown | 323 | Exercise of derivative | $0.00 | |
| 16th June 2020 | Michael J Brown | 20,000 | Bona fide gift | $0.00 | |
| 12th June 2020 | Michael J Brown | 85,000 | Bona fide gift | $0.00 | |
| 31st March 2020 | Christopher M Starr | 322 | Exercise of derivative | $0.00 | |
| 31st March 2020 | Raymond Anderson | 322 | Exercise of derivative | $0.00 | |
| 31st March 2020 | Michael J Brown | 322 | Exercise of derivative | $0.00 | |
| 31st March 2020 | Arthur J Klausner | 322 | Exercise of derivative | $0.00 |
Monopar Therapeutics
Monopar Therapeutics, Inc. engages in developing orphan oncology drugs. The company was founded by Chandler D. Robinson, Christopher M. Starr and Andrew P. Mazar in December 2014.
Ticker: MNPR
Sector: Health Technology
Industry: Biotechnology
SEC Central Index Key (CIK): 1645469
Employees: 7
Exchange: NASDAQ
Auditor Opinion:
You must Login to see Language Changes
Disclosure Language changes
You must Login to see analysis
Red Flags
We weren't able to import Fundamental data from the SEC disclosure.
There were no Red Flags found
Fundamentals
We weren't able to import Fundamental data from the SEC disclosure.
News
Behind real estate’s surprise 2020 boom and what comes next
24th October 2020
US judge will not reverse decision on WeChat app store ban
23rd October 2020